Navigation Links
Vion Pharmaceuticals Files for Chapter 11 Bankruptcy
Date:12/17/2009

ilable on the website of the court's claims agent at www.delclaims.com.

For additional information on Vion and its product development programs, visit the Company's Internet web site at www.vionpharm.com.

This news release contains forward-looking statements. Such statements are subject to certain risk factors which may cause Vion's plans to differ or results to vary from those expected, including Vion being unsuccessful in selling its assets or engaging in another transaction in bankruptcy, the FDA not approving Vion's Special Protocol Assessment for a Phase III randomized trial for Onrigin(TM) sponsored by HOVON, Vion not obtaining court approval of its motions in the Chapter 11 proceeding pursued by it from time to time, Vion's ability to develop, pursue, confirm and consummate one or more plans of reorganization with respect to the Chapter 11 case, Vion's ability to retain and compensate key executives and other key employees, Vion's ability to maintain relationships with its licensor and vendors, Vion's potential inability to obtain regulatory approval for its products, particularly Onrigin(TM), delays in the regulatory approval process, particularly for Onrigin(TM), delays or unfavorable results of drug trials, the need for additional research and testing, including the need for a randomized trial of Onrigin(TM) prior to regulatory approval, the inability to manufacture product, the potential inability to secure external sources of funding to continue operations, the
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Wash. , May 22, 2015  BioLife Solutions, Inc. ... of proprietary clinical grade hypothermic storage and ... for cells and tissues ("BioLife" or the "Company"), announced ... Marcum MicroCap Conference. The Company is scheduled ... Wednesday, May 27, 2015 at the Grand Hyatt Hotel in ...
(Date:5/22/2015)... May 22, 2015 The leading companies ... billion global cardiac rhythm management device market dominate ... that Medtronic, St. Jude Medical, Boston Scientific and ... this market segment. The healthcare market research publisher,s ... uses 2015 as a base year, providing forecasts ...
(Date:5/22/2015)... 22, 2015  The U.S. Food and Drug ... the first biosimilar product approved in ... growth in the contract manufacturing organization (CMO) industry, ... is geared to the production of small-molecular drugs ... products. The healthcare market research publisher,s report, ...
Breaking Medicine Technology:BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 4Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
... Odyssey Thera, Inc. announced today that the United ... No. 7,855,167.  The invention describes technologies and high-throughput ... based on protein-fragment complementation assays (PCA).  The ... protects assays utilizing fragments of inherently fluorescent proteins, ...
... N.J., Jan. 5, 2011 Amicus Therapeutics (Nasdaq: ... John F. Crowley will be presenting a business update and ... at the upcoming 29th Annual J.P. Morgan Healthcare Conference.  Mr. ... at 3:00 p.m. PST. Individuals can listen to ...
Cached Medicine Technology:
(Date:5/25/2015)... Burke Rehabilitation Hospital will welcome Samuel ... York City, to speak at Burke on Wednesday, June 3. ... Lobby Lecture series, will take place at 4:30 p.m. on ... grandson of Stanford White of McKim, Mead and White, the ... 100 years ago. , “We are thrilled to welcome Samuel ...
(Date:5/24/2015)... May 24, 2015 The Rolling Stones ... 24th in San Diego at Petco Park. This iconic ... On May 20th, they had a warmup show in ... preview show in Los Angeles, this beloved band not only ... played fan favorites such as "Jumping Jack Flash," "Moonlight ...
(Date:5/24/2015)... Metamora, Michigan (PRWEB) May 24, 2015 ... allow them to take pressure measurements in patients’ bladder ... The doctor usually orders it if they have reported ... (OAB). , Women’s Excellence in Bladder Control ... with unwanted urinary leakage or problems with overall control ...
(Date:5/24/2015)... York, New York (PRWEB) May 24, 2015 ... testosterone treatment lawsuits ( http://www.testosteronelawsuithub.com/ ) has scheduled ... the progress of the multidistrict litigation. According to ... Northern District of Illinois, the Conference will be ... (In re: Testosterone Replacement Therapy Product Liability Litigation ...
(Date:5/24/2015)... Scottsdale, Arizona (PRWEB) May 24, 2015 ... hired former Millennial Media strategy executive Jay Krihak ... as Medicx looks to ramp up its expertise ... services of the Pharmaceutical and Health sectors. , ... ad tech executive. Most recently, Krihak led sales ...
Breaking Medicine News(10 mins):Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 2Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 3Health News:The Rolling Stones Tickets in San Diego, Orlando, Minneapolis, Dallas, Pittsburgh, Indianapolis, Atlanta, Detroit, Milwaukee, Kansas City, Columbus, Nashville & Raleigh 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 3Health News:Medicx Media Solutions Expands Executive Team 2
... ASPH commends President Barack Obama,s appointment of New ... as the new Director of the Centers for Disease ... Obama hailed Frieden as "an expert in preparedness and ... public health challenges in our country and abroad will ...
... Designed to Help Employers and Business Owners Plan for ... Inc. is hosting two free webinars on May 19, ... flu pandemic. Following the webinar Health Advocate will release ... summarizing steps for employers to take.Two ...
... traditional remedy , , FRIDAY, May 15 (HealthDay News) ... centuries, and now its reputation for improving health ... the herb, which is used in traditional Chinese ... from the University of Hong Kong identified seven ...
... found in bloodstream could improve heart attack treatments , , ... is more readily absorbed into the bloodstream, making it ... incident, University of California, San Diego researchers report. , ... aspirin in their blood shortly afterward when compared with ...
... The American Association of Clinical Endocrinologists ... and ACE) today released a Position Statement ... a strong statement in support of continuing ... and industry.(Logo: http://www.newscom.com/cgi-bin/prnh/20090324/DC88061LOGO-b )The statement, ...
... medical blogger and health 2.0 consultant, presented ... , that aims to provide diabetes patients and ... quality and selected diabetes information. It lists diabetes blogs, ... others, from the best quality. All the web 2.0 ...
Cached Medicine News:Health News:ASPH Supports President Obama's Selection of New York City Health Commissioner Thomas R. Frieden, MD, MPH, for CDC Director 2Health News:Experts to Discuss Worksite Preparedness Measures During May 19th Pandemic Flu Webinars 2Health News:New Insights Show Ginseng Fights Inflammation 2Health News:Major Physician Group Issues Statement in Support of Physician/Industry Relationships 2Health News:Major Physician Group Issues Statement in Support of Physician/Industry Relationships 3
... Shaker provides the exact agitation needed ... very slow to fast speed and ... a gentle wave motion that lifts ... membranes to achieve faster, more uniform ...
Conversion Kits For Modular Incubator Chamber...
Inquire...
Inquire...
Medicine Products: